Sunrest Lifescience has fixed August 10, 2026, as the record date.

This determines eligibility for its 1:1 Rights Issue.

Shareholders on record will be entitled to apply for one new equity share (face value Rs.10) for every existing share they hold, allowing them to expand their stake.